Rachel Cervantes

Innovation, science and football junkie now living in San Diego.

Opinions expressed are those of my own.

[Rachel Cervantes @rbcBD]

@minakimes This and the two momentum-changing sacks is what makes DL2 a godsend. Apparently our special teams thought we were getting too comfortable.

[Rachel Cervantes @rbcBD]

@bradloncar I'm now in San Diego but miss Philly frequently and still truly believe it is a huge untapped source of innovation

[Rachel Cervantes @rbcBD]

@MikeHuckman @RealChemistry_ @HSBC @DamonRunyon @ldtimmerman Hoping for a cancellation too!

[Rachel Cervantes @rbcBD]

@bradloncar Both the Rose and the Sugar were amazing. Hoping actual championship is just as exciting!

[Rachel Cervantes @rbcBD]

@Skyline_Chili 🍰 Craving Skyline in California

[Rachel Cervantes @rbcBD]

@skathire @Penn Congratulations! Big welcome to your son

[Rachel Cervantes @rbcBD]

@AppleHelix It's why we all need big pharma to invest in vaccines. It's extremely hard for any other sort of entity to pay for clinical trials of that magnitude.

[Daniel Gerlach @gerlach_d]

Just 10 years ago ⁦@kevansf⁩ published his seminal work on targeting “the master of oncogenes” - today we have two FDA approved KRAS G12C inhibitors in the clinic and many more in development #eacrMAPKpathway https://t.co/ceHh40tkZJ

[UCSF Helen Diller Family Comprehensive Cancer Ctr @UCSFCancer]

Congratulations @kevansf @UCSF, winner of the 2023 @theNASciences Award for Scientific Discovery for pioneering breakthroughs in chemical biology to advance cancer therapy! To be awarded at the 160th NAS Annual Meeting! https://t.co/sndH0KFqGx #UCSFProud #NASaward #academia #HHMI

[Rachel Cervantes @rbcBD]

@GoBEARCATS I’m a diehard Bearcat and love the Kelce bros. But in this case…Who Dey

[Aɴᴛᴏɴɪᴏ Pᴀssᴀʀᴏ @APassaroMD]

💡🔥Out today, the Oncogene-addicted metastatic NSCLC ESMO Guideline. A significant effort to improve the management of patients w/ #lungcancer harbouring 🔟 different gene alterations! This is an amazing manuscript & I am glad to be a part of it #LCSM
https://t.co/eWsCg0osxk

[Norbert Kraut @norbertkraut1]

The KRAS crowd targets its next cancer mutations https://t.co/EWucPYSzoV
Insightful piece by @AsherMullard on drugging #KRAS beyond G12C mutants in @NatRevDrugDisc #KRASG12D #panKRAS inhibitors, molecular glues, degraders and more to come.

[Rich Eisen @richeisen]

“Better send in those refunds,” @JoeyB says to all the fans who bought tickets to the neutral field AFC Championship Game in Atlanta that will now not take place.

[Rachel Cervantes @rbcBD]

@WMoneyball Unsure why it would be unfair (although I agree Zac Taylor favors the pass even in cases when he shouldn't). I also think there's a difference between a quick slant that the Ravens force vs. a Josh Allen-type bomb.

[Rachel Cervantes @rbcBD]

@daphnezohar COVID neg/RSV neg/Flu neg but JPM virus positive.

[Rachel Cervantes @rbcBD]

@VentureValkyrie My male colleague complained today about the line to the men's bathroom at the W Hotel today. JPM is the Bizarro World of bathrooms.

[Rachel Cervantes @rbcBD]

@drsam The alert scared the bejeezus out of me

[Jay Bradner, M.D. @jaybradner]

A path to patients. We developed LXH254 B/CRAF as TT for patients with NRAS mutated melanoma. Thrilled by today’s news of a committed, expert path to study at Erasca $ERAS. Congratulations to all NIBR innovators, cancer drug developers, and BD&L heroes. https://t.co/cKdYF25mhw

[Rachel Cervantes @rbcBD]

@PabloTorre @emilymkaplan I was excited as @PabloTorre in listening to this. Gotta start watching hockey. Salamat @emilymkaplan !!

[Rachel Cervantes @rbcBD]

@Schwab5AM @5amVentures WhoDey!!